MediBuddy, India's largest digital healthcare company, has announced a strategic partnership with ELECOM, a leading Japa...
Clinically, Alexion has made substantial strides in the treatment of rare and debilitating conditions. A...
Beam Therapeutics, a leader in the gene-editing field, continues to make significant progress in its mission to ...
Argenx, a global leader in immunology, has made significant strides in 2024, bolstering its position as a pioneer in the...
Bluebird Bio, a pioneering company in the gene therapy sector, has made significant strides in 2024, showcasing both ope...
Alnylam Pharmaceuticals achieved significant progress in both its scientific and commercial ...
Novavax made significant strides in advancing its vaccine portfolio while solidifying its financial and operatio...
Vertex Pharmaceuticals made substantial strides in its therapeutic pipeline, achieved key regulatory approvals, ...
Sarepta Therapeutics achieved remarkable milestones in gene therapy and muscular dystrophy treatments during the first h...
With significant achievements across various therapeutic areas. The company’s progress included robust cli...
From January to June 2024, Moderna solidified its position as a leader in biotechnology, making substantial progress acr...
From January to June 2024, Illumina demonstrated a dynamic and transformative approach to its business, marking a period...
Between January and June 2024, Gilead Sciences made substantial progress across multiple therapeutic areas, reinforcing ...
Between January and June 2024, Genentech, a leading biotechnology company, made significant ...
From January to June 2024, CSL Limited reinforced its position as a global leader in biopharmaceuticals, making signific...
Between January and June 2024, CRISPR Therapeutics solidified its position as a pioneer in gene-editing technology with ...
BioNTech SE (Nasdaq: BNTX), a global leader in immunotherapy and innovative vaccine development, has reported significan...
Biogen's activities from January to June 2024 reflect a period of strategic initiatives, clinical advancements, and or...
